Sign in / Join Now
ETFs & Funds
- I'm in at an avg of $2.12. I like this one.
Add a reply...
Latest StockTalks »
people get BLRX breaking news and analysis by email alert.
Get email alerts on BLRX »
Get latest price
From other sites
BioLineRx Announces Initiation Of Immuno-Oncology Phase 2 Study To Investigate Combination Of BL-8040 And KEYTRUDA® For Pancreatic Cancer
at TheStreet (Tue, 7:00AM)
BioLineRx To Present At Biotech Showcase 2017 Conference In San Francisco
at TheStreet (Jan 4, 2017)
BioLineRx Presents Positive Phase 2a AML Study And Mechanism-of-Action Data For BL-8040 Oncology Platform At ASH 2016
at TheStreet (Dec 5, 2016)
BioLineRx In-licenses Novel Anti-Inflammatory Treatment For Dry Eye Syndrome Under Strategic Collaboration With Major Global Pharmaceutical Company
at TheStreet (Nov 21, 2016)
BioLineRx To Report Third Quarter Results On November 22, 2016
at TheStreet (Nov 15, 2016)